Lack of efficacy of hydroxychloroquine in covid-19

Affiliations

Editorial

Joseph M Vinetz. BMJ. 2020.

. 2020 May 19:369:m2018.

doi: 10.1136/bmj.m2018.

¹ Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8022, USA.

No abstract available

Conflict of interest statement

Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies.

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
Mahévas M, Tran VT, Roumier M, Chabrol A, Paule R, Guillaud C, Fois E, Lepeule R, Szwebel TA, Lescure FX, Schlemmer F, Matignon M, Khellaf M, Crickx E, Terrier B, Morbieu C, Legendre P, Dang J, Schoindre Y, Pawlotsky JM, Michel M, Perrodeau E, Carlier N, Roche N, de Lastours V, Ourghanlian C, Kerneis S, Ménager P, Mouthon L, Audureau E, Ravaud P, Godeau B, Gallien S, Costedoat-Chalumeau N. Mahévas M, et al. BMJ. 2020 May 14;369:m1844. doi: 10.1136/bmj.m1844. BMJ. 2020. PMID: 32409486 Free PMC article.
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W, Wu Y, Xiao W, Liu S, Chen E, Chen W, Wang X, Yang J, Lin J, Zhao Q, Yan Y, Xie Z, Li D, Yang Y, Liu L, Qu J, Ning G, Shi G, Xie Q. Tang W, et al. BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849. BMJ. 2020. PMID: 32409561 Free PMC article. Clinical Trial.